[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346362-105":59,"doc-detail-346362-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-amino-acid-differences-define-h2b-variants-and-modify-chromatin-accessibility-to-induce-emt-in-breast-cancer","Single amino-acid differences define H2B variants and modify chromatin accessibility to induce EMT in breast cancer","","Breast cancer development and progression are shaped by epigenetic and chromatin-level alterations. Histone variants can reshape histone-DNA interactions and chromatin architecture, yet H2B variants remain insufficiently characterized. This study shows H2B variants are dysregulated in breast cancer and associate with specific subtypes. HIST1H2BO overexpression is linked to poorer prognosis, while in vitro work indicates H2B1O compacts nucleosomes, activates pro-inflammatory and oncogenic pathways, induces EMT, and confers resistance to first-line chemotherapy, positioning H2B1O as an onco-histone biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-amino-acid-differences-define-h2b-variants-and-modify-chromatin-accessibility-to-induce-emt-in-breast-cancer/346362/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-amino-acid-differences-define-h2b-variants-and-modify-chromatin-accessibility-to-induce-emt-in-breast-cancer/346362.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the paper address about histone biology in breast cancer?","Question",{"text":112,"@type":113},"It addresses how histone variants can alter chromatin structure and gene regulation in cancer, noting that H2B variants are comparatively understudied despite evidence for other histone variants.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are H2B variants linked to breast cancer subtypes and prognosis?",{"text":117,"@type":113},"The study reports that H2B variants are dysregulated in breast cancer, with certain variants associated with specific subtypes. In particular, HIST1H2BO overexpression is linked to worse prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects does H2B1O have in vitro?",{"text":121,"@type":113},"In vitro studies show H2B1O compacts nucleosome structure and, when incorporated into chromatin, activates pro-inflammatory and oncogenic pathways, induces EMT, and produces resistance to first-line chemotherapeutic agents.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346362,1790444761,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Oncogene [www.nature.com/onc](www.nature.com/onc)  \nARTICLE OPEN   \nSingle amino-acid differences deﬁne H2B variants and modify chromatin accessibility to induce EMT in breast cancer  \nHejer Dhahri 1,2,3, Kin H. Lau 1, Wesley N. Saintilnord1,2,4,5, Elisson Lopes1, Hannah N. Damico 1, Youssef A. Hegazy 1,  \nFlavio R. Palma 6,7, Daniël P. Melters 8, Darrell P. Chandler1, Yamini Dalal 8, Jonathan D. Licht 9, Marcelo G. Bonini 6,7 and Yvonne N. Fondufe-Mittendorf1 ✉  \n© The Author(s) 2026  \n\n| | Histones scaffold genomic DNA and regulate access to the transcriptional machinery. However, naturally occurring histone variants can alter histone-DNA interactions, DNA and histone modiﬁcations, and the chromatin interactome. Hence, alterations in histone variant deposition can disrupt chromatin, and are increasingly recognized as a way to trigger various disease, including cancer. While signiﬁcant attention has been placed on the biochemical and functional roles of H2A, H3, and H4 histone variants, the variants of H2B remain largely understudied. Here, we show that H2B variants are dysregulated in breast cancer and that certain variants are associated with speciﬁc breast cancer subtypes. HIST1H2BO overexpression (in particular) is more common in Asian, African American/Black, and young female populations and is associated with a worse prognosis. In vitro studies show that H2B1O compacts nucleosome structure. Incorporating H2B1O into chromatin activates pro-inﬂammatory and oncogenic pathways, induces epithelial-to-mesenchymal transition (EMT), and generates resistance to ﬁrst-line chemotherapeutic agents. Thus, H2B1O acts much like an onco-histone, with H2B variant expression being a prognostic biomarker for breast cancer and a potential new target for drug therapies to enhance treatment efﬁcacy.\u003Cbr>Oncogene (2026) 45:669–689; [https://doi.org/10.1038/s41388-025-03636-1](https://doi.org/10.1038/s41388-025-03636-1) | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nGraphical Abstract  \nA full list of author afﬁliations appears at the end of the paper.  \nReceived: 3 August 2025 Revised: 1 October 2025 Accepted: 12 November 2025  \nPublished online: 24 January 2026  \nH. Dhahri et al.  \n670  \nINTRODUCTION  \nBreast cancer is a complex disease characterized by wide-ranging genetic and epigenetic alterations. Inter-tumor heterogeneity results in diverse clinical presentations across patients, to include signiﬁcant variations in angiogenic, invasive, and metastatic potential [1–5], and has a signiﬁcant impact on patient prognosis, treatment options, response to therapy, and metastatic sites [6–8] . Advances in genomic/transcriptomic proﬁling and histopathological examinations have enabled the ﬁeld to identify new and distinct factors contributing to breast cancer etiology, such that breast cancer can now be categorized into luminal A, luminal B, human epidermal growth factor receptor 2 positive (HER2+), triple-negative breast cancer (TNBC), and basal-like non-TNBC molecular sub-types. This classiﬁcation scheme is largely based on the estrogen receptor (ER), progesterone receptor (PR), and HER2 receptor expression levels [9–11], and is widely used to guide treatment decisions [12] .  \nCurrently, several breast cancer epigenetic therapies are being explored, including histone deacetylase inhibitors (HDACi), DNA methyltransferase inhibitors (DNMTi), and lysine methyltransferase inhibitors (KMTi), alone or in combination with immunotherapy [13, 14] . While some of these epigenetic therapies hold promise for treating breast cancer [15, 16], their clinical application is constrained by several limitations. A major challenge is the lack of speciﬁcity of commonly used agents as often these drugs lead to widespread changes in gene expression that may reactivate tumor suppressors but also oncogenes, leading to unpredictable responses and narrow therapeu","cbCaiftl4T3wLIY4","https://ap.wps.com/l/cbCaiftl4T3wLIY4","pdf",6527627,21,"English","# Introduction\n## Breast cancer heterogeneity and epigenetic therapy context\n## Histone variants and transcriptional access\n## Study focus on H2B variants","[{\"question\":\"What problem does the paper address about histone biology in breast cancer?\",\"answer\":\"It addresses how histone variants can alter chromatin structure and gene regulation in cancer, noting that H2B variants are comparatively understudied despite evidence for other histone variants.\"},{\"question\":\"How are H2B variants linked to breast cancer subtypes and prognosis?\",\"answer\":\"The study reports that H2B variants are dysregulated in breast cancer, with certain variants associated with specific subtypes. In particular, HIST1H2BO overexpression is linked to worse prognosis.\"},{\"question\":\"What functional effects does H2B1O have in vitro?\",\"answer\":\"In vitro studies show H2B1O compacts nucleosome structure and, when incorporated into chromatin, activates pro-inflammatory and oncogenic pathways, induces EMT, and produces resistance to first-line chemotherapeutic agents.\"}]","Single amino-acid differences define H2B variants and modify chromatin accessibility to induce EMT in breast cancer | PDF",1790061113,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e71c7bb926f0c9892666961c8aceb0a.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3008ef74e9e905873eb7000b2aa6afa1.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c47a98052fab49cb9513bacf3cfa50b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2310506c8cfb801aed79da940dce37f.webp",980,1301]